FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

OncoCalendar

« All Events

  • This event has passed.

The 24th Annual IBC East Conference

Jul 11 • 8:00 AM - Jul 12 • 5:00 PM
The 24th Annual IBC East Conference

The 24th Annual IBC East Conference will be held from July 11- July 12, 2025 at New York, US.

The 24th Annual IBC East Conference will provide clinicians with the latest updates on the treatment of breast cancer, covering advancements from preclinical research to changes in clinical treatment approaches.

The program focuses on novel therapies, molecular subtyping, and emerging data that are shaping the future of breast cancer therapy. Participants will explore the practical implications of these advances, including how to individualize patient care based on the newest evidence.

This event offers a unique opportunity for medical, surgical, and radiation oncologists, as well as other healthcare professionals, to learn from global leaders in the field of breast cancer. The goal is to improve patient outcomes by enhancing knowledge, applying new data to practice, and optimizing treatment plans. Attendees will gain insights into genomic and molecular biomarkers, multidisciplinary care, safety and efficacy data, and investigational therapies, with a focus on optimizing care for both early-stage and metastatic breast cancer patients.

Details

Start:
Jul 11 • 8:00 AM
End:
Jul 12 • 5:00 PM
Website:
https://www.gotoper.com/courses/international-congress-on-the-future-of-breast-cancer-east

Venue

InterContinental New York Barclay
111 East 48th St, New York
New York, 10017 United States + Google Map
Phone
+1 212-755-5900
View Venue Website